[HTML][HTML] Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis

AR Maher, M Maglione, S Bagley, M Suttorp, JH Hu… - Jama, 2011 - jamanetwork.com
Context Atypical antipsychotic medications are commonly used for off-label conditions such
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …

Psychopharmacological treatment of obsessive-compulsive disorder (OCD)

A Del Casale, S Sorice, A Padovano… - Current …, 2019 - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

[PDF][PDF] Practice guideline for the treatment of patients with obsessive-compulsive disorder

American Psychiatric Association, LM Koran… - 2007 - academia.edu
PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …

[HTML][HTML] Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

GS Dichter, CA Damiano, JA Allen - Journal of neurodevelopmental …, 2012 - Springer
This review summarizes evidence of dysregulated reward circuitry function in a range of
neurodevelopmental and psychiatric disorders and genetic syndromes. First, the …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008 - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

The pharmacologic treatment of anxiety disorders: a review of progress

LN Ravindran, MB Stein - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

MH Bloch, A Landeros-Weisenberger, B Kelmendi… - Molecular …, 2006 - nature.com
As many as half of obsessive-compulsive disorder (OCD) patients treated with an adequate
trial of serotonin reuptake inhibitors (SRIs) fail to fully respond to treatment and continue to …

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

DS Baldwin, IM Anderson, DJ Nutt… - Journal of …, 2005 - journals.sagepub.com
These British Association for Psychopharmacology guidelines cover the range and aims of
treatment for anxiety disorders. They are based explicitly on the available evidence and are …

Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines

S Pallanti, L Quercioli - Progress in Neuro-Psychopharmacology and …, 2006 - Elsevier
While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-
compulsive disorder (OCD), up to 40–60% of patients do not have a satisfactory outcome …